Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,068 | -54,410 | -42,058 | -29,522 | -13,220 |
| Depreciation Amortization | 381 | 2,602 | 2,147 | 1,503 | 767 |
| Accounts receivable | -2,217 | 7,352 | 1,257 | -6,949 | -7,678 |
| Other Working Capital | 283 | 31,977 | 12,266 | 282 | -4,678 |
| Other Operating Activity | 2,301 | 2,660 | 8,153 | 13,642 | 10,327 |
| Operating Cash Flow | $8,816 | $-9,819 | $-18,235 | $-21,044 | $-14,482 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -1,024 | -998 | -781 | -104 |
| Purchase Sale Intangibles | N/A | -1,500 | -1,500 | N/A | N/A |
| Other Investing Activity | 0 | -1,500 | -1,500 | 0 | 0 |
| Investing Cash Flow | $-2 | $-2,524 | $-2,498 | $-781 | $-104 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,113 | -2,025 | -1,350 | -675 | N/A |
| Common Stock Issued | 916 | 13,620 | 12,711 | 12,171 | 1,298 |
| Other Financing Activity | -8 | -3 | -3 | 0 | 0 |
| Financing Cash Flow | $-9,205 | $11,592 | $11,358 | $11,496 | $1,298 |
| Beginning Cash Position | 27,273 | 28,024 | 28,024 | 28,024 | 28,024 |
| End Cash Position | 26,882 | 27,273 | 18,649 | 17,695 | 14,736 |
| Net Cash Flow | $-391 | $-751 | $-9,375 | $-10,329 | $-13,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,816 | -9,819 | -18,235 | -21,044 | -14,482 |
| Capital Expenditure | -2 | -1,024 | -998 | -781 | -104 |
| Free Cash Flow | 8,814 | -10,843 | -19,233 | -21,825 | -14,586 |